We describe a novel expression cloning strategy in the fission yeast for the isolation of mammalian transcription factors using a mammalian promoter as target. This strategy is possible because of the conservation between mammalian cells and Schizosaccharomyces pombe of the mechanism that leads to the selection of the transcription start site. It also opens new perspectives to investigate the transcriptional regulation of genes for which detailed promoter analysis is difficult.
The power of yeast genetic selection has been used to establish an expression cloning system for transcription factors in Saccharomyces cerevisiae, commonly known as the 'yeast one-hybrid' strategy (1) . In this, an oligonucleotide containing several copies of a previously identified and short DNA recognition site for an unknown transcription factor is placed upstream of a yeast minimal promoter which directs the expression of a selectable marker (such as the HIS3 gene). A yeast strain (his3) containing this reporter construct is transformed with a library of mammalian cDNAs fused to a strong activation domain (such as GAL4 or VP16 activation domains) into a yeast expression plasmid. The expression of a putative transcription factor that binds to the target site of interest leads then to the activation of the selectable marker gene. However, the use of a long mammalian promoter fragment is not recommended in this screening because the mechanism that leads to the selection of the transcriptional start sites markedly differs between mammals and S.cerevisiae (2) . This may interfere with transcription efficiency of the mammalian promoter in budding yeast. Schizosaccharomyces pombe offers an interesting alternative. It is well known that the mechanism controlling the selection of the transcriptional initiation site(s) is more similar between S.pombe and mammalian cells (3) than between S.cerevisiae and mammalian cells. Based on these observations, we developed an alternative expression cloning strategy in S.pombe for the isolation of mammalian transcription factors using a mammalian promoter as a target.
The strategy is depicted in Figure 1B . The promoter of interest is fused to the NEO gene in pPIAde6NEO (4) . This reporter construct is stably integrated in the S.pombe genome at the ADE6 locus using double cross-over gene replacement. The promoter to be used in the screening has to be silent or weakly active in S.pombe, generating a reporter yeast which is unable to grow on medium containing G418. Subsequently, this reporter yeast is transformed with the cDNA library made in pSVX (Fig. 1A) . Expression of a putative transcription factor that binds to the promoter leads to activation of the NEO gene and formation of a colony on medium containing G418. In pSVX, the cDNA is expressed as fusion with the VP16 activation domain (5) . The use of this activation domain allows the isolation of any specific DNA-binding activities (including those of repressors) (6) . In addition, the SV40 early promoter drives expression of the cDNAs in pSVX. This offers the advantage that cDNA expression plasmids rescued from yeast colonies can be tested (after amplification in Escherichia coli) directly in a mammalian co-transfection assay for transcriptional activation of a suitable reporter plasmid.
To test the feasibility of the strategy, we have screened in S.pombe for transcription factors that modulate the activity of the human VCAM-1 promoter (7). The VCAM-1 (-1692, +12) promoter/NEO fusion was integrated in the genome of the S.pombe P3 strain (h -, ura4∆18, leu1). The integration of the VCAM-1/NEO reporter cassette did not increase the basal resistance level of the P3 strain (50 mg G418/l), suggesting that the activity of the VCAM-1 promoter in S.pombe is very low. We also determined the position of the initiation sites of transcription for that reporter construct in S.pombe; these sites coincide with those identified in mammalian cells (data not shown). Despite identical transcription initiation, the VCAM-1 promoter has a very low activity in S.pombe, suggesting that S.pombe lacks the homologues of the mammalian transcription factors required for controlling the expression of this promoter or, alternatively, that the yeast basic transcription machinery cannot recognise the VCAM-1 general promoter elements.
To test whether the VCAM-1 minimal promoter elements can be functional upon activation in S.pombe, we inserted a GAL4 binding site in the promoter (position -120), and transformed the reporter yeast established with this hybrid promoter construct with a pSVX expression vector for GAL4/VP16. This VCAM-1/GAL4 UAS hybrid promoter was induced 4-fold by GAL4/VP16, showing that the general VCAM-1 promoter elements such as the TATA box are functional in S.pombe, at least in combination with an acidic transactivation domain (data not shown). Therefore, we speculate that the VCAM-1 promoter is inactive in S.pombe due to the lack of homologues to mammalian factor(s) controlling VCAM-1 express-*To whom correspondence should be addressed. Tel: +32 16 34 59 29; Fax: + 32 16 34 59 33; Email: jre@sgi.celgen.kuleuven.ac.be ion. In addition, any VCAM-1 specific DNA-binding activity fused to VP16 activation domain is anticipated to induce transcription from the VCAM-1 promoter in S.pombe. We conclude from these observations that the VCAM-1 promoter fragment (-1692, +12) represents a suitable target for the isolation of transcription factors in the S.pombe expression cloning strategy.
A cDNA library made from non-activated human umbilical vein endothelial cells (HUVEC) mRNA was prepared in pSVX. The yeast (ura4, ade6) containing the VCAM-1 reporter was transformed (8) with 50 µg of this HUVEC library. The transformation mixture was first plated on minimal medium (MM)+Adenine medium (9) in order to select yeast colonies that acquired a cDNA expression plasmid. Because G418 blocks protein synthesis, this intermediate MM+Adenine selection step allows the positive yeast colonies to produce sufficient amounts of NEO protein prior to the G418 selection. 8 × 10 6 URA4 transformants were selected. These transformants were scraped from the plates into 20 different pools and each pool was grown for 6 h in 50 ml of YPD medium (9) . Approximately 5 × 10 6 cells from each pool were plated on YPD plates containing 200 mg G418/l. Five G418-resistant colonies were selected and shown to grow on plates containing up to 2000 mg G418/l, suggesting at least a 20-fold activation of the VCAM-1 promoter. We rescued plasmids from these positive colonies and amplified them in E.coli.
Sequencing of the cDNA revealed that all five plasmids contained the same cDNA coding for RelA (p65), a subunit of transcription factor NF-κB. RelA has previously been shown to regulate the VCAM-1 promoter in HUVEC (10) . Therefore, this successful screening illustrates the feasibility of this new S.pombe expression cloning strategy for the isolation of mammalian transcription factors.
Finally, pSVXRelA was transfected into Jurkat cells together with a 6NF-κB binding site/TK minimal promoter reporter construct. Expression of the reporter gene increased 14-fold by cotransfection with pSVXRelA as compared with pSVX (data not shown). These data confirmed that a functional RelA transcription factor is produced in mammalian cells from the yeast expression plasmid pSVXRelA. Hence, any pSVX-cDNA containing plasmids isolated from positive yeast colonies in the S.pombe screening can directly be analysed in mammalian cells without the need for any recloning step.
In conclusion, this new method offers several advantages in comparison with the conventional one-hybrid method in S.cerevisiae: (i) it enables one to screen with an entire mammalian promoter fragment avoiding the need for promoter characterization; (ii) the NEO marker allows the use of promoters that display some basal activity, because selection can be performed on G418 concentrations ranging from 100 to 2000 mg G418/l; (iii) the cDNA expression plasmid for S.pombe can be used directly in mammalian cells and this facilitates significantly the analysis of the positive colonies. Thus, our strategy represents a new and valuable method to investigate the transcriptional regulation of genes that are expressed in tissues for which no cell lines are available, and that allows the mapping of regulatory elements by transfection. The new method can also be applied to investigate the regulation of genes that are expressed during embryonic development, for which the use of a transgenic mouse approach is the only currently available alternative.
